257 related articles for article (PubMed ID: 32926213)
1. Molecular characterization of CNS paragangliomas identifies cauda equina paragangliomas as a distinct tumor entity.
Schweizer L; Thierfelder F; Thomas C; Soschinski P; Suwala A; Stichel D; Wefers AK; Wessels L; Misch M; Kim HY; Jödicke R; Teichmann D; Kaul D; Kahn J; Bockmayr M; Hasselblatt M; Younsi A; Unterberg A; Knie B; Walter J; Al Safatli D; May SA; Jödicke A; Ntoulias G; Moskopp D; Vajkoczy P; Heppner FL; Capper D; Hartmann W; Hartmann C; von Deimling A; Reuss DE; Schöler A; Koch A
Acta Neuropathol; 2020 Dec; 140(6):893-906. PubMed ID: 32926213
[TBL] [Abstract][Full Text] [Related]
2. The immunohistochemical, DNA methylation, and chromosomal copy number profile of cauda equina paraganglioma is distinct from extra-spinal paraganglioma.
Ramani B; Gupta R; Wu J; Barreto J; Bollen AW; Tihan T; Mummaneni PV; Ames C; Clark A; Oberheim Bush NA; Butowski N; Phillips D; King BE; Bator SM; Treynor EC; Zherebitskiy V; Quinn PS; Walker JB; Pekmezci M; Sullivan DV; Hofmann JW; Sloan EA; M Chang S; Berger MS; Solomon DA; Perry A
Acta Neuropathol; 2020 Dec; 140(6):907-917. PubMed ID: 32892244
[TBL] [Abstract][Full Text] [Related]
3. Cauda equina paragangliomas express HOXB13.
Bockmayr M; Körner M; Schweizer L; Schüller U
Neuropathol Appl Neurobiol; 2021 Oct; 47(6):889-890. PubMed ID: 33768604
[TBL] [Abstract][Full Text] [Related]
4. Locally invasive giant spinal paraganglioma.
Yi Chen B; Jose Mizrahi C; Yang Y; Kavar B
J Clin Neurosci; 2020 Aug; 78():430-432. PubMed ID: 32334958
[TBL] [Abstract][Full Text] [Related]
5. Cauda equina neuroendocrine tumors show biological features distinct from other paragangliomas and visceral neuroendocrine tumors.
Soukup J; Manethova M; Kohout A; Soukup T; Dvorakova R; Drugda J; Vitovcova B; Gabalec F; Kaiser M; Kanta M; Kasparova P; Kozak J; Michnova L; Netuka D; Reguli S; Rychly B; Trnkova M; Vachata P; Wozniakova M; Cesak T
Virchows Arch; 2023 Feb; 482(2):325-338. PubMed ID: 36348031
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical distinction of paragangliomas from epithelial neuroendocrine tumors-gangliocytic duodenal and cauda equina paragangliomas align with epithelial neuroendocrine tumors.
Mamilla D; Manukyan I; Fetsch PA; Pacak K; Miettinen M
Hum Pathol; 2020 Sep; 103():72-82. PubMed ID: 32668278
[TBL] [Abstract][Full Text] [Related]
7. SDH-B, INSM1, and GATA3 expression in cauda equina neuroendocrine tumors: report on 21 cases from a North indian tertiary care center.
Sood R; Chatterjee D; Bhardwaj S; Singla N; Ahuja C; Radotra B
Hum Pathol; 2023 Jul; 137():18-24. PubMed ID: 37100233
[TBL] [Abstract][Full Text] [Related]
8. Paraganglioma of the cauda equina region.
Corinaldesi R; Novegno F; Giovenali P; Lunardi T; Floris R; Lunardi P
Spine J; 2015 Mar; 15(3):e1-8. PubMed ID: 25452014
[TBL] [Abstract][Full Text] [Related]
9. Paraganglioma of the cauda equina: A clinicopathologic study of 12 cases with demonstration of cytokeratin positivity.
Zhang Y; Du Z; Xiong J; Wang Y; Yin B
Ann Diagn Pathol; 2022 Apr; 57():151887. PubMed ID: 35033938
[TBL] [Abstract][Full Text] [Related]
10. Paragangliomas in the cauda equina region: clinicopathoradiologic findings in four cases.
Yang SY; Jin YJ; Park SH; Jahng TA; Kim HJ; Chung CK
J Neurooncol; 2005 Mar; 72(1):49-55. PubMed ID: 15803375
[TBL] [Abstract][Full Text] [Related]
11. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
[TBL] [Abstract][Full Text] [Related]
12. Cauda equina neuroendocrine tumor: a report of three cases and review of the literature with focus on differential diagnosis and postoperative management.
Fabbrocini L; Zin F; Keyvani K; Ebner FH
Neurosurg Rev; 2024 Apr; 47(1):166. PubMed ID: 38632184
[TBL] [Abstract][Full Text] [Related]
13. Primary Paraganglioma of the Spine: A Systematic Review of Clinical Features and Surgical Management in Cauda Equina versus Non-Cauda Equina Lesions.
Palmisciano P; Sagoo NS; Haider AS; Ogasawara C; Ogasawara M; Bin Alamer O; Heidari KS; Raj KM; Scalia G; Umana GE; Krishnaney AA; Aoun SG; Passias PG; Vira S
World Neurosurg; 2022 May; 161():190-197.e20. PubMed ID: 35123022
[TBL] [Abstract][Full Text] [Related]
14. [Paraganglioma of the cauda equina].
Rickert CH; Probst-Cousin S; Schumacher HW; Gullotta F
Pathologe; 1997 Nov; 18(6):484-7. PubMed ID: 9451740
[TBL] [Abstract][Full Text] [Related]
15. Germline SDHD mutation in paraganglioma of the spinal cord.
Masuoka J; Brandner S; Paulus W; Soffer D; Vital A; Chimelli L; Jouvet A; Yonekawa Y; Kleihues P; Ohgaki H
Oncogene; 2001 Aug; 20(36):5084-6. PubMed ID: 11526495
[TBL] [Abstract][Full Text] [Related]
16. Paraganglioma of the cauda equina. Report of a rare tumor.
Taxy JB
Cancer; 1983 May; 51(10):1904-6. PubMed ID: 6831355
[TBL] [Abstract][Full Text] [Related]
17. [Paraganglioma of the cauda equina. Apropos of a case with review of the literature].
Bouraoui S; Kchir N; Haouet S; Zammel I; Chatti S; Khaldi M; Zitouna MM
Arch Anat Cytol Pathol; 1997; 45(1):37-42. PubMed ID: 9339002
[TBL] [Abstract][Full Text] [Related]
18. Paraganglioma of the cauda equina. A case report and review of the literature.
Bak J; Olsson Y; Grimelius L; Spännare B
APMIS; 1996 Mar; 104(3):234-40. PubMed ID: 8611199
[TBL] [Abstract][Full Text] [Related]
19. Cauda equina neuroendocrine tumors: A single institutional imaging review of cases over two decades.
Ajmera P; Agarwal AK; Mehta PM; Benson JC; Madhavan AA; Diehn FE; Soni N; Bathla G
Neuroradiol J; 2024 Feb; 37(1):84-91. PubMed ID: 37933451
[TBL] [Abstract][Full Text] [Related]
20. Cytokeratins expression in paragangliomas of the cauda equina.
Labrousse F; Leboutet MJ; Petit B; Paraf F; Boncoeur-Martel MP; Moreau JJ; Catanzano G
Clin Neuropathol; 1999; 18(4):208-13. PubMed ID: 10442464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
